首页> 美国卫生研究院文献>Cardiovascular Research >Uncoupling of myofilament Ca2+-sensitivity from troponin I phosphorylation by mutations can be reversed by Epigallocatechin-3-Gallate
【2h】

Uncoupling of myofilament Ca2+-sensitivity from troponin I phosphorylation by mutations can be reversed by Epigallocatechin-3-Gallate

机译:Epigallocatechin-3-Gallate可以逆转突变引起的肌丝Ca2 +敏感性与肌钙蛋白I磷酸化的解偶联

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AimsHeart muscle contraction is regulated via the β-adrenergic response that leads to phosphorylation of Troponin I (TnI) at Ser22/23, which changes the Ca2+-sensitivity of the cardiac myofilament. Mutations in thin filament proteins that cause Dilated Cardiomyopathy (DCM) and some mutations that cause Hypertrophic Cardiomyopathy (HCM) abolish the relationship between TnI phosphorylation and Ca2+-sensitivity (uncoupling). Small molecule Ca2+-sensitisers and Ca2+-desensitisers that act upon troponin alter the Ca2+-sensitivity of the thin filament but their relationship with TnI phosphorylation has never been studied before.
机译:目的通过β-肾上腺素能调节心脏的肌肉收缩,导致Ser22 / 23的肌钙蛋白I(TnI)磷酸化,从而改变心肌细丝的Ca 2 + 敏感性。引起扩张型心肌病(DCM)的细丝蛋白突变和导致肥厚型心肌病(HCM)的某些突变消除了TnI磷酸化与Ca 2 + -敏感性(解偶联)之间的关系。作用于肌钙蛋白的小分子Ca 2 + -敏化剂和Ca 2 + -脱敏剂改变了细丝的Ca 2 + 敏感性,但它们与TnI磷酸化的关系以前从未研究过。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号